期刊文献+

盐酸氯米帕明大鼠在体肠吸收动力学研究 被引量:2

Study on in situ intestinal absorption of clomipramine hydrochloride in rats
下载PDF
导出
摘要 目的研究盐酸氯米帕明在大鼠肠道的吸收特性。方法采用大鼠在体肠灌流实验方法,利用高效液相色谱法同时测定肠回流液中药物及酚红的浓度,通过酚红的浓度校正相应时刻供试液的体积。结果盐酸氯米帕明浓度为5、10、25μg/ml时小肠的吸收速率常数(ka)为(0.74±0.04)、(0.78±0.03)、(0.77±0.05)h-1;在十二指肠、空肠、回肠和结肠的ka分别为(0.590±0.026)、(0.670±0.032)、(0.680±0.030)和(0.560±0.031)h-1。结论盐酸氯米帕明在大鼠肠道均有良好的吸收。盐酸氯米帕明在小肠的吸收呈表观一级动力学过程,吸收机制为被动扩散。 Objective To investigate the intestinal absorption characteristics oi clomlpramme hydrochlonde in different intestine segments of rats. Methods The in situ intestinal absorption of clomipramine hydrochloride was studied by in situ recirculation perfusion technique. The concentrations of clomipramine hydrochloride and phenol red in the perfusate were determined simultaneously by reversed-phase HPLC. Phenol red was used to calibrate the volume of the perfusate. Results The absorption rate constant of clomipramine hydrochloride at concentrations of 5, 10, 25 μg/ml were (0.74±0.04),(0.78±0.03),(0.77±0.05) h^-1 respectively. At duodenum, jejunum, ileum and colon, the permeability coefficient of clomipramine hydrochloride were (0.590±0.026), (0.670±0.032), (0.680±0.030), (0.560±0.031) h^-1 respectively. Conclusion Clomipramine hydrochloride can be absorbed by the whole intestine segments. The absortion of clomipramine hydrochloride is apparent first-order process with passive diffusion mechanism.
出处 《中国药物与临床》 CAS 2009年第8期679-681,共3页 Chinese Remedies & Clinics
基金 山西省归国留学人员科研项目(200529) 太原市科技兴市项目(07020425)
关键词 盐酸氯米帕明 色谱法 高压液相 肠吸收 吸收速率常数 Clomipramine hydrochloride Chromatography, high pressure liquid Intestinal absorption Absorption rate constant
  • 相关文献

参考文献2

  • 1周焱,董碧蓉.抑郁症治疗的系统评价证据[J].中国实用内科杂志,2001,21(6):336-338. 被引量:4
  • 2Balimane PV,Chong SH,Morrlson RA.Current methodologies used for evaluation of intestinal permeability and absorption.J Pharmacol Toxicol Methods,2000,44(1):301-312.

共引文献3

同被引文献21

  • 1白敏,丁平田,谢俊霞,魏薇.石杉碱甲大鼠在体肠吸收动力学研究[J].中南药学,2005,3(4):211-213. 被引量:13
  • 2聂淑芳,潘卫三,李伟,杜玍妮.长春西汀的大鼠在体肠吸收研究[J].中国医药工业杂志,2005,36(10):625-628. 被引量:21
  • 3聂淑芳,潘卫三,杨星钢,刘宏飞,刘志东.对大鼠在体肠单向灌流技术中重量法的评价[J].中国新药杂志,2005,14(10):1176-1179. 被引量:90
  • 4杨星钢,张立波,潘卫三,张建援.芍药苷大鼠在体肠吸收动力学的研究[J].中国药学杂志,2006,41(11):854-857. 被引量:24
  • 5郭歆,曹伟,程泽能,黄志壮,李焕德.齐墩果酸大鼠肠吸收动力学[J].中南药学,2007,5(3):216-219. 被引量:17
  • 6Sato T,Kawamoto A,Tamura A,et al.Mechanism of antioxi-dant action of pueraria glycoside (PG) -1 (an isoflavonoid) and mangiferin (a xanthonoid)[J].Chem Pharn Bull (Tokyo),1992,40 (3):721-724.
  • 7Ichiki H,Miura T,Kubo M,et al.New antidiabetic compounds,mangiferin and its glucoside[J].Biol Pharm Bull,1998,21(12):1389-1390.
  • 8Yoshimi N,Matsunaga K,Katayama M,et al.The inhibitory effects of mangiferin,a naturally occurring glucosylxanthone,in bowel carcinogenesis of male F344 rats[J].Cancer Lett,2001,163 (2):163-70.
  • 9Martinez G,Giuliani A.Leon OS,et al.Effect of Mangifera India L.extract (QF808) on protein and hepatic microsome peroxidation[J].Phytother Res,2001,15 (7):581-585.
  • 10Muruganandan S,Gupta S,Kataria M,et al.Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats[J].Toxicology,2002,176 (3):165-173.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部